Your browser doesn't support javascript.
loading
Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh Decade.
Nesher, Eviatar; Braun, Marius; Eizner, Sigal; Issachar, Assaf; Cohen, Michal; Shlomai, Amir; Gurevich, Michael; Tur-Kaspa, Ran; Mor, Eytan.
Afiliação
  • Nesher E; Department of Transplantation, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
  • Braun M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Eizner S; Liver Diseases Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
  • Issachar A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cohen M; Department of Transplantation, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
  • Shlomai A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Gurevich M; Liver Diseases Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
  • Tur-Kaspa R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Mor E; Liver Diseases Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
Isr Med Assoc J ; 20(12): 765-769, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30550007
ABSTRACT

BACKGROUND:

The lack of organs for liver transplantation has prompted transplant professionals to study potential solutions, such as the use of livers from donors older than 70 years. This strategy is not widely accepted because potential risks of vascular and biliary complications and recurrence of hepatitis C.

OBJECTIVES:

To examine the efficacy and safety of liver grafts from older donors for transplantation.

METHODS:

A retrospective analysis of data on 310 adults who underwent deceased donor liver transplantation between 2005 and 2015 was conducted. We compared graft and recipient survival, as well as major complications, of transplants performed with grafts from donors younger than 70 years (n=265, control group) and those older than 70 years (n=45, older-donor group), followed by multivariate analysis, to identify risk factors.

RESULTS:

There was no significant difference between the control and older-donor group at 1, 5, and 10 years of recipient survival (79.5% vs. 73.3%, 68.3% vs. 73.3%, 59.2% vs. 66.7%, respectively) or graft survival (74.0% vs. 71.0%, 62.7% vs. 71.0%, 54.8% vs. 64.5%, respectively). The rate of biliary and vascular complications was similar in both groups. Significant risk factors for graft failure were hepatitis C (hazard ratio [HR] = 1.92, 95% confidence interval [95%CI] 1.16-2.63), older donor age (HR = 1.02, 95%CI 1.007-1.031), and male gender of the recipient (HR = 1.65, 95%CI 1.06-2.55).

CONCLUSIONS:

Donor age affects liver graft survival. However, grafts from donors older than 70 years may be equally safe if cold ischemia is maintained for less than 8 hours.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Fígado / Seleção do Doador / Isquemia Fria / Sobrevivência de Enxerto Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Isr Med Assoc J Ano de publicação: 2018 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Fígado / Seleção do Doador / Isquemia Fria / Sobrevivência de Enxerto Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Isr Med Assoc J Ano de publicação: 2018 Tipo de documento: Article